Document Detail

Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis.
MedLine Citation:
PMID:  23370736     Owner:  NLM     Status:  In-Data-Review    
Objective Some angiotensin receptor blockers (ARBs), including irbesartan, increase the peroxisome proliferator-activated receptor (PPAR)-g activity in vitro. The aim of this study was to evaluate the interactions between obesity and the effects of irbesartan on inflammatory cytokines in chronic glomerulonephritis patients without diabetes. Methods The anti-inflammatory effects of irbesartan were evaluated in 29 hypertensive chronic glomerulonephritis patients without diabetes in a prospective, single-arm study. Results Following treatment with irbesartan for 26 weeks, blood pressure and proteinuria significantly decreased, as previously reported (blood pressure decreased from 142±1/87±1 to 131±1/81±1 mmHg and the urine protein/creatinine ratio decreased from 1,030±143 to 779±121 mg/g Cr). BMI did not significantly change after the study. Among the inflammatory parameters, the concentrations of adiponectin and high-sensitivity C-reactive protein (hsCRP) significantly improved after treatment; however, the changes in the concentrations of interleukin-6 (IL-6), tumor necrosis factor (TNF)-a and leptin did not reach statistical significance. Moreover, the changes in these five parameters following treatment were moderately correlated with the BMI values obtained at the initiation of the study, and the improvements were particularly prominent in those with a BMI greater than 25. Improvements in proteinuria were significantly correlated with increases in the adiponectin concentration, but not with BMI. There was also a moderate correlation between the changes in the adiponectin and insulin concentrations. Conclusion Irbesartan improves metabolic parameters in nondiabetic hypertensive chronic glomerulonephritis patients, especially those with a high BMI. Improving the adiponectin concentration may be important for reducing proteinuria.
Shuichi Tsuruoka; Hirayasu Kai; Joichi Usui; Naoki Morito; Chie Saito; Keigyo Yoh; Kunihiro Yamagata
Related Documents :
25031086 - Common variants in pcsk1 influence blood pressure and body mass index.
8002526 - Effect of hyperoxia at 1 and 2 ata on hypoxia and hypercapnia in human skin during expe...
8610866 - The effect of thoracic epidural anesthesia on hypoxic pulmonary vasoconstriction in dog...
17137816 - Contractile properties of the functionally divided python heart: two sides of the same ...
1530996 - Brain natriuretic peptide as a cardiac hormone in essential hypertension.
7998586 - Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothia...
Publication Detail:
Type:  Journal Article     Date:  2013-02-01
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  52     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2013  
Date Detail:
Created Date:  2013-02-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  303-8     Citation Subset:  IM    
Department of Nephrology, Faculty of Medicine, University of Tsukuba, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Status of dyslipidemia treatment in Japanese adults: an analysis of the 2009 Japan society of ningen...
Next Document:  The validity and usefulness of the Japanese version of the calgary sleep apnea quality of life index...